Table 1 Summary of patient demographics and kidney transplantation background by treatment group (intent-to-treat population)
| Â | Everolimus 1.5 mg (n= 61) | MMF 2 g (n= 61) |
|---|---|---|
Recipient characteristics | ||
Age (years) | Â | Â |
 Mean ± standard deviation | 42.5 ± 14.13 | 38.6 ± 11.36 |
 Median (range) | 42.0 (18 to 65) | 36.0 (20 to 64) |
Gender, n (%) | Â | Â |
 Male | 46 (75.4) | 37 (60.7) |
 Female | 15 (24.6) | 24 (39.3) |
Body mass index (kg/m2) | Â | Â |
 Mean ± standard deviation | 22.46 ± 4.03 | 21.79 ± 2.78 |
 Median (range) | 21.97 (15.5 to 37.5) | 21.09 (16.0 to 27.6) |
Primary disease leading to transplantation, n (%) | Â | Â |
 Glomerulonephritis/glomerular disease | 16 (26.2) | 9 (14.8) |
 Polycystic disease | 3 (4.9) | 3 (4.9) |
 Hypertension/nephrosclerosis | 5 (8.2) | 2 (3.3) |
 Diabetes mellitus | 3 (4.9) | 5 (8.2) |
 Interstitial nephritis | 2 (3.3) | 0 (0.0) |
 Obstructive disorder/reflux | 6 (9.8) | 3 (4.9) |
 IgA nephropathy | 11 (18.0) | 16 (26.2) |
 Unknown | 8 (13.1) | 16 (26.2) |
 Other | 7 (11.5) | 7 (11.5) |
Current dialysis | Â | Â |
 None | 12 (19.7) | 8 (13.1) |
 Hemodialysis | 42 (68.9) | 48 (78.7) |
 Peritoneal dialysis | 7 (11.5) | 5 (8.2) |
HLA mismatches | Â | Â |
 1 | 7 (11.5) | 2 (3.3) |
 2 | 9 (14.8) | 16 (26.2) |
 3 | 25 (41.0) | 24 (39.3) |
 <3 | 16 (26.2) | 18 (29.5) |
 ≥3 | 45 (73.8) | 43 (70.5) |
Donor characteristics | ||
Mean ± standard deviation age (years) | 52.3 ± 8.99 | 55.2 ± 8.23 |
Deceased heart beating, n (%) | 1 (1.6) | 0 (0.0) |
Deceased nonheart beating, n (%) | 0 (0.0) | 1 (1.6) |
Living related, n (%) | 36 (59.0) | 43 (70.5) |
Living unrelated, n (%) | 24 (39.3) | 17 (27.9) |